New combination treatments in the management of asthma: focus on fluticasone/vilanterol.

导出 LinkOut

翻译打印收藏纠错

作者： Laren D,Tan ^[1] ; Andrew L,Chan ^[1] ; Timothy E,Albertson ^[2]

作者单位： Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, CA ; Department of Medicine, Veterans Administration Northern California Health Care System, Mather, CA. ^[1] Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, CA ; Department of Medicine, Veterans Administration Northern California Health Care System, Mather, CA ; Department of Emergency Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA. ^[2]

关键词 asthma treatments inhaled corticosteroids (ICS)long-acting beta2-agonist (LABA)

DOI 10.2147/JAA.S39625

PMID 24833910

发布时间 2022-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览41

Journal of asthma and allergy

2014年7卷

77-83页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

New combination treatments in the management of asthma: focus on fluticasone/vilanterol.

Journal of asthma and allergy

相似文献

Journal of asthma and allergy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

New combination treatments in the management of asthma: focus on fluticasone/vilanterol.

Journal of asthma and allergy

相似文献

Journal of asthma and allergy

相关期刊

检索历史清除